Different Role of Advanced Glycation End Products in Pathology of Transplanted Heart in Patients With or Without Diabetes Mellitus Type 2

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 3185-3189

  Zakliczynski, M ^a   Nozynski, J ^a   Konecka Mrowka, D ^a   Pyka, L ^a   Trybunia, D ^a   Nikiel, B ^b   Mlynarczyk Liszka, J ^b   Lange, D ^b   Zembala, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CONNECTIVE TISSUE; CONTROLLED STUDY; FEMALE; HEART GRAFT; HEART MUSCLE BIOPSY; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; STROMA CELL;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; PILOT PROJECTS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 70350454605     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.07.069     Document Type: Article

References (14)

1. Gearhart M.M., and Parbhoo S.K. Hyperglycemia in the critically ill patient. AACN Clin Issues 17 (2006) 50
2. Bloom R.D., and Crutchlow M.F. Transplant-associated hyperglycemia. Transplant Rev (Orlando) 22 (2008) 39
3. Jandeleit-Dahm K., and Cooper M.E. The role of AGEs in cardiovascular disease. Curr Pharm Des 14 (2008) 979
4. Schleicher E.D., Wagner E., and Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99 (1997) 457
5. Goh S.Y., and Cooper M.E. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93 (2008) 1143
6. Brownlee M., Vlassara H., Kooney A., et al. Aminoguanidine prevents diabetes- induced arterial wall protein cross-linking. Science 232 (1986) 1629
7. Yoshida N., Okumura K., and Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 54 (2005) 345
8. Li S.Y., Sigmon V.K., Babcock S.A., et al. Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes. Life Sci 80 (2007) 1051
9. Hartog J.W., Voors A.A., Bakker S.J., et al. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail 9 (2007) 1146
10. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9 (1990) 587
11. Nożyński J., Zakliczyński M., Konecka-Mrówka D., et al. Advanced glycation end products (AGE) in the pathogenesis of ischaemic cardiomyopathy in diabetic patients-preliminary report. Kardiochir Torakochir Pol5 (2008) 56
12. Heidland A., Sebeková K., Frangiosa A., et al. Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation. Heart 90 (2004) 1269
13. Taylor D.O., Edwards L.B., Aurora P., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 27 (2008) 943
14. Mehra M.R. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant 6 (2006) 1248